title: Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides.
abstract: BACKGROUND
  There is a need for reliable, easily measurable laboratory markers that may help dermatologists to predict the course of mycosis fungoides (MF) when they first evaluate their patients.
  
  
  OBJECTIVE
  Our objective was to identify clinical, haematological or immunological parameters as predictors of mortality in patients with MF.
  
  
  METHODS
  We conducted a retrospective study on a prevalent cohort of 124 patients with MF hospitalized at IDI-IRCCS, Rome, Italy, from 1983 to 2001. We calculated the proportion of patients surviving (Kaplan-Meier product-limit estimates) 5 and 10 years after first hospital admission, and hazard ratios (HR) from the Cox proportional hazards model.
  
  
  RESULTS
  Patients' survival was linked to age and staging (lower survival in older patients and in patients with staging IIB-IV). Higher numbers of white blood cells (WBC) and neutrophils, lower numbers of CD8+ lymphocytes, low haematocrit and lower levels of albumin were significantly associated with a lower survival probability. When simultaneously accounting for age and staging, CD8+ [HR = 3.02, 95% confidence interval (CI) 1.01-9.07 for CD8+ < 250 vs. > or = 600 cells microL(-1)] and WBC (HR = 2.59, 95% CI 0.96-6.96 for WBC > or = 9000 vs. < 6000 cells microL(-1)) were associated with survival. In addition, we observed an exceedingly high risk of death (HR = 12.40, 95% CI 3.11-49.43) for patients with a combination of WBC > or = 9000 and CD8+ < 600 cells microL(-1) vs. WBC < 9000 and CD8+ > or = 600 cells microL(-1)).
  
  
  CONCLUSIONS
  The measurement of CD8+ cells and WBC in MF seems to be a promising criterion to predict survival, and possibly to support treatment decisions and inclusion of patients in randomized controlled trials.
authors.affiliation: Istituto Dermopatico dell'Immacolata IDI-IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy. d.abeni@idi.it
authors.forename: D
authors.initials: D
authors.lastname: Abeni
authors.forename: M
authors.initials: M
authors.lastname: Frontani
authors.forename: F
authors.initials: F
authors.lastname: Sampogna
authors.forename: F
authors.initials: F
authors.lastname: Sera
authors.forename: S
authors.initials: S
authors.lastname: Bolli
authors.forename: R
authors.initials: R
authors.lastname: Corona
authors.forename: G
authors.initials: G
authors.lastname: Baliva
authors.forename: G
authors.initials: G
authors.lastname: Russo
mesh_terms: D000367:Age Factors; D000368:Aged; D000418:Albumins / Q000032:analysis; D001772:Blood Cell Count / Q000379:methods; D018414:CD8-Positive T-Lymphocytes; D005260:Female; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000097:blood* / Q000401:mortality*; D009367:Neoplasm Staging; D009504:Neutrophils; D010586:Phagocytes; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000097:blood* / Q000401:mortality*; D016019:Survival Analysis
chemical_list: D000418:Albumins